Chiral Chemicals to 2005 - Market Size, Market Share, Demand Forecast, Sales, Company Profiles, Market Research, Industry Trends
April 24, 2007 (Press Release) --
Chiral Chemicals to 2005 - Market Size, Market Share, Demand Forecast, Sales, Company Profiles, Market Research, Industry Trends
Chiral Chemicals to 2005 - Market Size, Market Share, Demand Forecast, Sales, Company Profiles, Market Research, Industry Trends : Chiral chemical demand in the US will grow over nine percent annually through 2005. Pharmaceutical uses will lead gains as regulations and competition spur new and reformulated drugs containing single isomer active ingredients. The fastest growing chiral end-uses will include cancer therapies, antihistamines, antivirals, anorexics, antibiotics and antidiabetics.
This study analyzes the $9.6 billion US chiral chemicals industry. It presents historical data (1990, 1995, 2000) and forecasts to 2005 and 2010 by type (e.g., hormones, anti-infective chemicals, cardiovascular chemicals, central nervous system chemicals, respiratory chemicals, diagnostic and research chemicals, agricultural chemicals, food and beverage additives); and by end-use market.
The study also examines the market environment, reviews chiral technologies and materials, details industry structure and market share, and profiles over 40 key companies including Abbott Laboratories, Ajinomoto, Akzo Nobel, Amgen, BASF, Bristol-Myers Squibb, Cambrex, Dow Chemical, Eastman Chemical, Eli Lilly, GlaxoSmithKline, Kyowa Hakko Kogyo, Novartis, Pfizer, Rhodia, and Schering-Plough.
For more information, Please visit : http://www.bharatbook.com/detail.asp?id=8634
or email us at : info@bharatbook.com
You can also call us at +91-(022)-2757 8668 or +91-(022)-2757 9131
For searching our huge collection of reports, Please visit :
http://www.bharatbook.com/general/customresearch.asp
Chiral Chemicals to 2005 - Market Size, Market Share, Demand Forecast, Sales, Company Profiles, Market Research, Industry Trends
Chiral Chemicals to 2005 - Market Size, Market Share, Demand Forecast, Sales, Company Profiles, Market Research, Industry Trends : Chiral chemical demand in the US will grow over nine percent annually through 2005. Pharmaceutical uses will lead gains as regulations and competition spur new and reformulated drugs containing single isomer active ingredients. The fastest growing chiral end-uses will include cancer therapies, antihistamines, antivirals, anorexics, antibiotics and antidiabetics.
This study analyzes the $9.6 billion US chiral chemicals industry. It presents historical data (1990, 1995, 2000) and forecasts to 2005 and 2010 by type (e.g., hormones, anti-infective chemicals, cardiovascular chemicals, central nervous system chemicals, respiratory chemicals, diagnostic and research chemicals, agricultural chemicals, food and beverage additives); and by end-use market.
The study also examines the market environment, reviews chiral technologies and materials, details industry structure and market share, and profiles over 40 key companies including Abbott Laboratories, Ajinomoto, Akzo Nobel, Amgen, BASF, Bristol-Myers Squibb, Cambrex, Dow Chemical, Eastman Chemical, Eli Lilly, GlaxoSmithKline, Kyowa Hakko Kogyo, Novartis, Pfizer, Rhodia, and Schering-Plough.
For more information, Please visit : http://www.bharatbook.com/detail.asp?id=8634
or email us at : info@bharatbook.com
You can also call us at +91-(022)-2757 8668 or +91-(022)-2757 9131
For searching our huge collection of reports, Please visit :
http://www.bharatbook.com/general/customresearch.asp
Email
Print
SPAM
LEAVE A COMMENT
